Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06021782 · ClinicalTrials.gov registry record
Characterization of the Pudendal Nerve with Transvaginal Ultrasonography
A clinical trial of Anesthesia, sponsored by University of Virginia.
- Recruiting
- Registry status
- 24
- Enrollment target
- 1
- Study location
NCT06021782: Recruiting study of Anesthesia, sponsored by University of Virginia.
NCT06021782 is a study of Anesthesia that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 24 participants, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06021782, a study of Anesthesia, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a feasibility study characterizing the ability of transvaginal ultrasonography to identify the pudendal nerve. Today, the pudendal nerve block is typically accomplished through blind landmark techniques, thus limiting its success. To date, there has never been an attempt to determine if the visualization of the pudendal nerve would be possible using transvaginal ultrasound with existing technology; nor to perform this procedure transvaginally with the assistance of ultrasound.
Primary Outcome
We will use this study to determine if we can use transvaginal ultrasound to visualize the pudendal nerve through transvaginal ultrasound.
Conditions Studied
Interventions
- OTHER All subjects-Observation
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-05-13 |
| Est. Completion | 2026-12 |
What NCT06021782 shows while recruiting
NCT06021782 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Anesthesia appearing as the primary indexed condition, and to 1 intervention - of which All subjects-Observation is the first listed.
NCT06021782 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06021782 about?
NCT06021782 is a clinical study titled "Characterization of the Pudendal Nerve with Transvaginal Ultrasonography". This is a feasibility study characterizing the ability of transvaginal ultrasonography to identify the pudendal nerve. Today, the pudendal nerve block is typically accomplished through blind landmark techniques, thus limiting its success. To date, there has never been an attempt to determine if the ...
What is the current status of trial NCT06021782?
This trial is currently recruiting. The enrollment target is 24 participants. The study started on 2021-05-13. Estimated completion is 2026-12.
What conditions does trial NCT06021782 study?
This clinical trial studies the following conditions: Anesthesia.
What interventions are being tested in trial NCT06021782?
The interventions under investigation include: All subjects-Observation (OTHER).
Who is sponsoring clinical trial NCT06021782?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06021782 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06021782's enrollment target sits among peer trials
24 48th of 57 higher than 10 of 57 other Anesthesia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anesthesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study
RECRUITING · Phase 4
-
Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration
RECRUITING · Phase 3
-
The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes
RECRUITING
-
Oral Methadone in Cardiac Surgery
RECRUITING · Phase 4
-
Remimazolam NeuroImaging
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI